The effects of a 2-h trial of high-flow oxygen by nasal cannula versus Venturi mask in immunocompromised patients with hypoxemic acute respiratory failure: a multicenter randomized trial

INTRODUCTION: In immunocompromised patients, acute respiratory failure (ARF) is associated with high mortality, particularly when invasive mechanical ventilation (IMV) is required. In patients with severe hypoxemia, high-flow nasal oxygen (HFNO) therapy has been used as an alternative to delivery of...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Crit Care
Autori principali: Lemiale, Virginie, Mokart, Djamel, Mayaux, Julien, Lambert, Jérôme, Rabbat, Antoine, Demoule, Alexandre, Azoulay, Elie
Natura: Artigo
Lingua:Inglês
Pubblicazione: BioMed Central 2015
Soggetti:
Research
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4629403/
https://ncbi.nlm.nih.gov/pubmed/26521922
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13054-015-1097-0
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi